AdvanCell Closes A$18M Series B Funding Led by Morningside
14.9.2022 17:16:00 EEST | Business Wire | Press release
AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced today the closing of an A$18 million Series B financing round led by Morningside.
Andrew Adamovich, CEO and Founder of AdvanCell noted, “We are very pleased with our progress to date and delighted that we will continue our rapid growth with the support of our shareholders. We have had a long-term relationship with our lead investor, Morningside, and are excited to come closer still to our goal to 'Change the Course of Cancer Treatment.'”
Targeted Alpha Therapies represent the most exciting opportunity to treat currently untreatable cancers. The technology harnesses the natural decay and radiochemical properties of certain elements, in combination with specific targeting molecules, to selectively deliver cell-killing radiation to the tumour cell. AdvanCell believes this precise and powerful treatment will rapidly become a leading pillar of cancer treatment, providing treatments for diseases for which there are currently no effective options. Targeted Alpha Therapies demonstrate incredible efficacy, however widespread adoption and large commercial product launches require a scalable and reliable global isotope supply. AdvanCell was established to solve this problem.
AdvanCell’s ability to produce isotope on-demand and at scale, and its in-house radiopharmaceutical manufacturing expertise positions AdvanCell to play a leading role in this rapidly growing market. With additional support from NSW Health Medical Devices Fund and the Federal government’s Research & Development Tax Incentive, AdvanCell has developed a world-first scalable manufacturing platform to produce alpha-emitting isotopes for research, pre-clinical and clinical use and to advance its own and its partners' radiopharmaceutical products.
Anthony Aiudi from Morningside commented, “AdvanCell is leveraging its ability to make alpha isotopes at scale and in clinically useful amounts along with its radiochemistry expertise, to develop an exciting portfolio of Targeted Alpha Therapies. Targeted Alpha Therapies hold incredible promise however their development has been hamstrung by a lack of radioisotope supply. Together with the team at AdvanCell, we look forward to writing a new chapter in oncology, to target large patient populations with significant unmet needs.”
Mr Aiudi has been appointed to the Board of AdvanCell, joining Mr Adamovich, Bill Ferris AC, co-founder of CPE Capital, Adrian “Adi” Patterson, former Australian Nuclear Science and Technology Organisation (ANSTO) CEO and Kevin Cameron, CEO of Ionetix.
Bill Ferris AC, Chair remarked, “Our executive team has articulated a credible pre-clinical and clinical pathway for the delivery of the Company’s novel Targeted Alpha Therapies. Having successfully developed the manufacturing platform essential for the reliable and scalable supply of isotopes, the Company is on schedule with its pre-clinical work and is now moving into first-in-human trials. AdvanCell is on track to become a leading radiopharmaceutical company with a platform technology enabling novel cancer treatments.”
About AdvanCell
AdvanCell is a radiopharmaceutical company developing next-generation cancer treatment. AdvanCell’s Targeted Alpha Therapies are powered by a platform technology – a world-first alpha isotope generator that addresses the greatest unmet need in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell has a world-class team and is honoured to be advised by an outstanding Board of Directors and Scientific Advisory Board. For more information visit www.advancell.com.au
About Morningside
Founded in 1986 by the Chan family, Morningside is a technology and life science venture investment firm. With offices in Boston, Shanghai and London, the firm invests globally. The group is managed by investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate. Morningside partners with academic founders and entrepreneurs to build world-class companies that want to markedly improve the current state of medicine today and ultimately, the lives of patients. In addition to its investment activities, Morningside Ventures is strongly committed to social responsibility. For more information visit www.morningside.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005846/en/
Contact information
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM and Real Asset Acquisition Corp. Announce Public Filing of Form F-4 Registration Statement with the SEC14.5.2026 16:55:00 EEST | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced today the public filing of a registration statement on Form F-4 (the “Registration Statement”), which includes a preliminary proxy statement, with the U.S. Securities and Exchange Commission (“SEC”) in connection with the proposed Business Combination Agreement announced February 23, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514989293/en/ IQM Radiance quantum computer Jan Goetz, Chief Executive Officer and Co-Founder, IQM, said: “This filing is a milestone we have worked hard to reach, and it signals our readiness to operate at a new level. Public markets will give IQM the platform and capital to accelerate everything we are building as we work towards delivering fault-toleranc
MOBX to Acquire U.S. Defense Rare Earth, Critical Minerals Company14.5.2026 16:40:00 EEST | Press release
Mobix Labs (Nasdaq: MOBX) today announced a non-binding Letter of Intent to acquire Special Project Delivery LLC ("SPD"), a U.S. company building sovereign supply chains for rare earth elements, critical minerals, and energy storage. The proposed acquisition would extend Mobix Labs' national security work — already supplying U.S. and allied fighter jets, missiles, submarines, and satellites — directly into one of the world's most strategically important industrial sectors. MOBX is moving directly into the supply chain powering modern defense, aerospace, and AI infrastructure. Forward-Looking Statements This press release contains forward-looking statements regarding the proposed acquisition of Special Project Delivery LLC ("SPD"), which are subject to risks and uncertainties described in Mobix Labs' SEC filings and similar provisions under applicable non-U.S. securities laws. The Letter of Intent is non-binding, and there can be no assurance that a definitive agreement will be executed
Flick Raises $6M Seed Round to Redefine How AI Films Are Created14.5.2026 16:19:00 EEST | Press release
Flick (flick.art), an AI-native filmmaking platform founded by award-winning filmmaker Zoey Zhang and founding Instagram engineer Ray Wang, today announced it has raised $6 million in a seed round from True Ventures, GV (Google Ventures), Y Combinator, Lightspeed, Formosa Capital, Pioneer Fund, Olive Tree Capital, and N1 in addition to angel investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514408256/en/ Flick was built around a simple belief: AI should enhance filmmaking, not replace it. Instead of another one-click video generator, Flick gives filmmakers cinematic control through an AI-native creative workflow designed for storytelling, iteration, and artistic direction. Flick will use the seed funding to accelerate product development, expand its core creative tooling for cinematic control, and grow the company’s community of filmmakers. The team is also launching Flick Filmmaker Residency,debuting with 10+ sho
PIF Named as Official Tournament Supporter of FIFA World Cup 2026™14.5.2026 16:08:00 EEST | Press release
PIF and FIFA has announced PIF as an Official Tournament Supporter in North America and Asia of the FIFA World Cup 2026™. The partnership reflects a shared commitment to expanding the growth of football at every level, from the grassroots to elite competition, as well as enabling greater participation in sport by unlocking new opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514974404/en/ 14 May, 2026: Front row (L-R), Romy Gai, Chief Business Officer, FIFA and Kevin Foster, Managing Director and Head of Corporate Affairs, PIF, back row (L-R), H.R.H Prince Faisal Bin Bandar Bin Sultan Al Saud, Vice Chairman, Savvy Games Group, Gianni Infantino, President, FIFA, H.E. Yasir Othman Al-Rumayyan, Governor, PIF and Muhannad AlDawood, Chief Strategy Officer, Qiddiya Investment Company witnessed the signing of the partnership of PIF as Official Tournament Supporter of FIFA World Cup 2026™, incorporating PIF companies
Planet Releases First Light from Latest Pelican Launch, Including Imagery from Sweden’s First Sovereign Satellite14.5.2026 16:04:00 EEST | Press release
Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today released first light images from its latest Pelican launch, including the Swedish Armed Forces (SwAF)’s first ever sovereign satellite. Planet launched these three Pelican spacecraft to orbit aboard the CAS500-2 rideshare mission with SpaceX from Vandenberg Space Force Base in California on May 3, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514665846/en/ Ambursu, Nigeria • May 11, 2026 • Altitude: 510 km • Pelican Planet received high-resolution first light imagery from the Pelican satellites within days of their May 3 launch. Each satellite captured imagery from around the world, including Gotland, Sweden, on May 7, 2026, from an altitude of 515 km; Taiyuan, in Shanxi, China, on May 5, 2026, from an altitude of 512 km; and Ambursu, Nigeria, on May 11, 2026, from an altitude of 510 km. As the spacecraft complete
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom